These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15853213)

  • 1. [A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
    Hatae M; Takahashi T; Kodama S; Nakayama H; Kuzuya K; Saji F; Kamiura S; Watanabe Y; Nishimura R; Kono I; Ariyosh Y; Fukuoka M; Imajo Y; Hasegawa K; Noda K; ;
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):473-8. PubMed ID: 15853213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S; Kobayashi K; Ohira H; Seino H; Hashimoto N; Sawai K; Samejima Y; Saji F
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy with nedaplatin (CDGP) and 5-FU for oral cancer].
    Maruoka Y; Ando T; Hoshino M; Ogiuchi Y; Nishihara N; Okamoto T; Fukada K; Kuwazawa T; Ogiuchi H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):421-5. PubMed ID: 11915732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
    Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer].
    Fujii M; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J; Ohno Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):53-8. PubMed ID: 9464329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
    Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
    Yamamoto N; Tamura T; Kurata T; Yamamoto N; Sekine I; Kunitoh H; Ohe Y; Saijo N
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):79-88. PubMed ID: 19396598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of docetaxel and nedaplatin for recurrent squamous cell carcinoma of the uterine cervix.
    Watanabe Y; Nakai H; Etoh T; Kanemura K; Tsuji I; Ishizu A; Hoshiai H
    Anticancer Res; 2008; 28(4C):2385-8. PubMed ID: 18751423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
    Takemura H; Kobayashi S; Katsuno M; Asano R; Morimoto M; Tachibana S; Kubota H; Iida M; Kadokura Y; Sanbe T
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2065-9. PubMed ID: 16352930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
    Sekine I; Sumi M; Ito Y; Kato T; Fujisaka Y; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2007 Mar; 37(3):175-80. PubMed ID: 17452427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S; Okuda T; Ikeda M; Ishihara S; Itoh Y; Yanagawa S; Ishigaki T
    Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma.
    Mitsuhashi A; Uno T; Tanaka N; Suzuka K; Tate S; Yamazawa K; Matsui H; Yamamoto S; Ito H; Sekiya S
    Gynecol Oncol; 2005 Jan; 96(1):194-7. PubMed ID: 15589600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trial.
    Bell MC; Davidson SA; Mathis JM; Ampil F
    Gynecol Oncol; 2001 Feb; 80(2):128-31. PubMed ID: 11161849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
    Kodaira T; Fuwa N; Tachibana H; Hidano S
    Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
    Zhu WG; Yu CH; Li T
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.